In this context, considering that irisin has been found to be low in patients with type 2 diabetes [39], the statin-associated increase in irisin concentrations may indeed represent a protective compensatory reaction of the muscle cell. The gene discussed is FNDC5; the disease is type 2 diabetes mellitus.